Quick COVID-19 Test-and-Treat model tested in five african nations
NCT ID NCT06360783
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a fast COVID-19 test-and-treat program in Ghana, Malawi, Rwanda, Zambia, and Zimbabwe. Researchers interviewed health officials, workers, and patients to see if the program was practical and well-liked. The goal was to learn how to set up similar programs in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this model could help countries quickly test and treat COVID-19 patients in the future.
- What could go wrong
- This was a small, completed study focused on gathering opinions, not on proving health outcomes. Results may not apply everywhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Global Health Institute
Durham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?